Post by Alvarez & Marsal

Private equity continues to lean into healthcare services, with global deal value reaching $190B in 2025, one of the strongest years on record.   As consolidation accelerates and technology adoption deepens, financial due diligence is evolving. Evaluating targets in isolation no longer captures the full picture. Platform readiness, cross-border integration complexity, and the real cost of scaling are becoming central to deal success and value creation.   Read more from the Global Transaction Advisory Group healthcare team on how FDD must adapt in this changing landscape, and what makes a healthcare asset truly platform-ready: https://okt.to/Fa5cOU #AMon #FinancialDueDiligence #PrivateEquity #MergersAndAcquisitions #Healthcare Paul Aversano, Xuong Liu, Stella Yuan, Jonathan Gibbons, Philip Mitchell, Scott Foster, Anthony Caporrino, Stacy Kirshner, Fabio G. Pires, Ashish Bansal, Bhavik Hathi, David Willis, Nonaka Daisaku, Mark Copeland, Kate Lowry, Andrew Henoch, Raheel Khan